Sentences with phrase «with different cancer»

A total of 1645 patients with different cancer diagnoses treated in hospitals and rehabilitation clinics filled in the latest 38 - item version of the QSC questionnaire.

«As cancer cells» entire metabolic machinery is shifted when they become malignant, their unique odor is evidently a signature the dogs are able to identify, with different cancer types having different signatures,» Otto says.

«Oncologists have the most updated treatment options and are familiar with different cancer behavior and adverse reactions to treatments,» said Heidi P. Watkins, DVM, a small animal veterinarian with Airport Irvine Animal Hospital in Costa Mesa, California.

An exciting area in drug development, immunotherapy is being increasingly utilized by patients with different cancer types.

Blueprint will see where it stands after adding more patients with different cancer types to the Phase 1 study and focusing more on how long their responses last, rather than just whether they respond at all.

These survivors have a variety of ages, with different cancers and prognoses.

Not exact matches

«In the long term, we want to be able to send energy to and communicate with implants all over the body, to record data from a variety of organs in many different ways, maybe even report on the conditions of tumors or cancer therapies,» Maharbiz says.

They're really heavily intertwined with our metabolism and have an enormous impact on our processing of food and on our health and disease and they've been linked to many different diseases to obesity, to diabetes, to heart disease, and even to cancer and Urological disease.

The IARC acknowledges the difficulty of determining causality, but their report concludes that, «the consistent associations of colorectal cancer with consumption of processed meat across studies in different populations, which make chance, bias, and confounding unlikely as explanations.»

«I've watched and had a lot of contact with people who have lived a better life because of cannabis, whether it's because they had cancer, or Crohn's, or a lot of different things.»

We're also making progress on our liquid biopsy program since our last update, including the recently announced collaboration with Memorial Sloan Kettering Cancer Center, which is focused on furthering the basic understanding of the biology of circulating tumor DNA, or ctDNA, in different cancer Cancer Center, which is focused on furthering the basic understanding of the biology of circulating tumor DNA, or ctDNA, in different cancer cancer types.

We included prospective studies that provided hazard ratios (HRs) with 95 % confidence intervals (CI) for at least three categories (including the reference group) of milk consumption in relation to mortality from all causes, overall cardiovascular disease, or overall cancer, We omitted studies that only reported results for total milk products or combined non-fermented and fermented milk because non-fermented and fermented milk may have different associations with mortality.

«My auntie died from cancer and on her last day she said, «I've worked every day with the plan of stopping one day and doing all these different things, and then I ran out of time.»

Each of us with breast cancer (and I include men) has a different set of genes, personal backgrounds and lifestyles.

Studies done with animals show that acrylamide in the diet increases the risk of developing several different types of cancer, including stomach and colon cancer and don't get me started on the salt levels.

Tops, an M.D. - trained deputy medical examiner at the Armed Forces Institute of Pathology (AFIP) in Washington, D.C., and Dorkina Myrick, an M.D. / Ph.D. physician - scientist, pathologist, and medical officer with the National Cancer Institute (NCI) in nearby Bethesda, Maryland, entered pathology from different directions.

At five years, disease - free survival was no different between the two groups, with 85.3 percent of men in the traditional group being cancer - free, compared to 86.3 percent of men in the shorter regimen group.

The study has been tested in metastatic patients with different primary tumours such as breast, colon and lung cancer.

Ohio State University medical oncologist and epidemiologist Maura Gillison has studied men with oropharyngeal cancer in three different decades.

Molecular characterization of the cells that undergo cell fate transition upon oncogenic Pik3ca expression demonstrated a profound oncogene - induced reprogramming of these newly formed cells and identified gene expression signatures, characteristic of the different cell fate switches, which was predictive of the cancer cell of origin, tumour type and clinical outcomes in women with breast cancers.

«Our findings suggest a paradigm shift from thinking of HPV16 as a single viral entity undergoing slow genetic drift to considering each HPV16 isolate to be a separate virus, with possibly different carcinogenic potential, which will necessarily lead to a re-interpretation of HPV natural history and carcinogenesis,» says lead author Lisa Mirabello of the National Cancer Institute, NIH.

«We have discovered the existence of a subgroup of cervical cancers with very different genetic features.

However, for patients with lymphoma, it may be a rather different story, as new research from the University of Copenhagen shows that toxins in the staphylococcus bacteria help cancer cells gain control over healthy cells.

Because of a chromosomal abnormality, this gene sometimes fuses with another gene and forms a hybrid, or a gene fusion, resulting in a gene product with an entirely different function, causing cancers.

Last summer, Italian and Dutch groups separately published papers suggesting that children are at wildly different risks for cancer depending on which defect they carry — with the risk ranging from less than 3 % to about 25 % — and argued that for lower - risk children, screening might not make sense.

«Different types of cancer cells with different strengths and weaknesses are both present in the tumor at the same time and can work together to spread faster and more effDifferent types of cancer cells with different strengths and weaknesses are both present in the tumor at the same time and can work together to spread faster and more effdifferent strengths and weaknesses are both present in the tumor at the same time and can work together to spread faster and more efficiently.

In the past, variation in ABO blood groups have been found to be associated with different risk of developing certain cancers, such as gastric and pancreatic cancers, and recently it has also been shown that prostate cancer incidence varies with blood group2.

Along with finding that the tumor suppressor protein SIRT6 is inactive in around 30 percent of cases of pancreatic ductal adenocarcinoma (PDAC), the team identified the precise pathway by which SIRT6 suppresses PDAC development, a mechanism different from the way it suppresses colorectal cancer.

Michele Carbone and colleagues, from the University of Hawaii, discovered that members of 4 families, apparently unrelated and living in different US States, shared the identical mutation of a gene called BAP1 that is associated with a higher incidence of mesothelioma, melanoma, renal carcinoma and other cancers.

Research based on such false cell lines would undermine the understanding of different cancers and possible treatments, and clutter the scientific literature with bogus conclusions.

The authors note that prior studies have reported elevated levels of distress among people with cancer, but they vary in quality due to small sample sizes, different diagnostic criteria and assessment standards, and an over-representation of women with breast cancer.

It is likely that in the long run, Digistain could help with the diagnosis of all different types of cancer.

«We're a very broad church, requiring many different areas of expertise,» says Fiona Watt, with the Cancer Research UK Cambridge Research Institute and the 2008 - 2009 president of the International Society for Stem Cell Research (ISSCR).

Cancer is a heterogeneous disease, with genetic variations occurring between different types of tumors and different patients.

Analysis of blood samples taken at several points in time from a group of patients with different forms of advanced metastatic breast cancer found CTC clusters in the blood of 35 percent of patients and that the survival of those with more clusters in their blood was significantly reduced.

«The phi test helps physicians distinguish prostate cancer from benign conditions by utilizing three different PSA markers (PSA, freePSA and p2PSA) as part of a sophisticated algorithm to more reliably determine the probability of cancer in patients with elevated PSA levels,» said Kevin Slawin, MD, director, Vanguard Urologic Institute at Memorial Hermann Medical Group, clinical professor of Urology at Baylor College of Medicine and director of Urology, Memorial Hermann Hospital ‐ Texas Medical Center, who performed some of the key research that led to the development of the phi test and who also began using the test in February.

For this project, researchers studied samples from 98 colorectal cancer patients with different mutations in KRAS and BRAF genes.

Sugen has identified 19 families of RTKs, and abnormalities in the way they function have already been linked with different types of cancer, as well as conditions such as diabetes.

Slusher teamed up with Johns Hopkins Kimmel Cancer Center immunologist Jonathan Powell, M.D., Ph.D., who has studied how cancer cells use different metabolic pathways to evade destruction by immune Cancer Center immunologist Jonathan Powell, M.D., Ph.D., who has studied how cancer cells use different metabolic pathways to evade destruction by immune cancer cells use different metabolic pathways to evade destruction by immune cells.

If metastatic cancers are most often made up of cells with different genetic drivers, perhaps researchers should be targeting the primary tumor with multiple drugs to contain the cancer.

To understand cancer and block its progression, scientists have identified which proteins are changed in different cancers, and targeted these with drugs that block their activities, so halting cancer progression.

They tested these drugs one at a time for lethal interaction with 112 different tumor - suppressor gene mutations in human cancer cells growing in the lab.

«Nanotechnology is promising great benefits to people with many different types of cancer, and it's exciting that it could one day offer the same hope to people with the most common form of dementia.»

For Helicobacter pylori, a pathogenic bacterium that colonizes over 40 percent of the world population and is associated with gastric cancer, the team discovered that epigenetic heterogeneity can quickly emerge as a single cell divides, and different subpopulations with distinct methylation patterns have distinct gene expressions patterns.

«Because the metabolites in cancer and normal cells are so different, we extract and analyze them with the MasSpec Pen to obtain a molecular fingerprint of the tissue.

If true, that might explain the cancer difference because women with more body fat tend to develop a different hormonal profile than leaner ones and ovarian cancer is a hormone - sensitive malignancy.

Tumor cells associated with pancreatic cancer often behave like communities by working with each other to increase tumor spread and growth to different organs.

«This is why some cancers can be so difficult to treat with chemotherapy, because the cells can be in different states — some sensitive to treatment and some resistant to treatment, all in the same tumor,» says Sandro Santagata, a former visiting scientist in the lab of Whitehead Member Susan Lindquist.

An analysis of mutations in the BRCA1 and BRCA2 genes reveals that women with breast cancer and women with ovarian cancer harbored mutations in different regions of the genes.

Efforts aimed at finding better drug regimens would therefore greatly benefit from a mouse model with an intrinsic marker that can indicate different stages of pancreatic tumor formation leading to cancer and reflect the effects exerted by novel drug candidates.